<VariationArchive RecordType="classified" VariationID="1691279" VariationName="NM_000138.5(FBN1):c.3534dup (p.Gln1179fs)" VariationType="Duplication" Accession="VCV001691279" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-06-11" MostRecentSubmission="2022-06-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1683758" VariationID="1691279">
      <GeneList>
        <Gene Symbol="FBN1" FullName="fibrillin 1" GeneID="2200" HGNC_ID="HGNC:3603" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48408313" stop="48645709" display_start="48408313" display_stop="48645709" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48700502" stop="48937984" display_start="48700502" display_stop="48937984" Strand="-" />
          </Location>
          <OMIM>134797</OMIM>
          <Haploinsufficiency last_evaluated="2019-12-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FBN1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-12-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FBN1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000138.5(FBN1):c.3534dup (p.Gln1179fs)</Name>
      <CanonicalSPDI>NC_000015.10:48487129:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48487129" stop="48487130" display_start="48487129" display_stop="48487130" variantLength="1" positionVCF="48487129" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48779326" stop="48779327" display_start="48779326" display_stop="48779327" variantLength="1" positionVCF="48779326" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>Q1179fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.48487130dup" Assembly="GRCh38">
            <Expression>NC_000015.10:g.48487130dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.48779327dup" Assembly="GRCh37">
            <Expression>NC_000015.9:g.48779327dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008805.2" sequenceAccession="NG_008805" sequenceVersion="2" change="g.163659dup">
            <Expression>NG_008805.2:g.163659dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000138.5" sequenceAccession="NM_000138" sequenceVersion="5" change="c.3534dup" MANESelect="true">
            <Expression>NM_000138.5:c.3534dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000129.3" sequenceAccession="NP_000129" sequenceVersion="3" change="p.Gln1179fs">
            <Expression>NP_000129.3:p.Gln1179fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_778" sequenceAccession="LRG_778">
            <Expression>LRG_778:g.163659dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2141293209" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000138.5(FBN1):c.3534dup (p.Gln1179fs) AND multiple conditions" Accession="RCV002254377" Version="4">
        <ClassifiedConditionList TraitSetID="76181">
          <ClassifiedCondition DB="MedGen" ID="C0024796">Marfan syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4310796">Progeroid and marfanoid aspect-lipodystrophy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-06-11" MostRecentSubmission="2022-06-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="76181" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="2645" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Marfan syndrome, classic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Marfan syndrome</ElementValue>
                <XRef ID="MONDO:0007947" DB="MONDO" />
                <XRef ID="19346006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan syndrome type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan's syndrome</ElementValue>
                <XRef ID="Marfan+syndrome/4466" DB="Genetic Alliance" />
                <XRef ID="19346006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MARFAN SYNDROME, TYPE I</ElementValue>
                <XRef Type="MIM" ID="154700" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MFS</ElementValue>
                <XRef Type="MIM" ID="154700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MFS1</ElementValue>
                <XRef Type="MIM" ID="154700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6975" />
                <XRef ID="6975" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FBN1-Related Marfan Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">FBN1-related Marfan syndrome (Marfan syndrome), a systemic disorder of connective tissue with a high degree of clinical variability, comprises a broad phenotypic continuum ranging from mild (features of Marfan syndrome in one or a few systems) to severe and rapidly progressive neonatal multiorgan disease. Cardinal manifestations involve the ocular, skeletal, and cardiovascular systems. Ocular findings include myopia (&gt;50% of affected individuals); ectopia lentis (seen in approximately 60% of affected individuals); and an increased risk for retinal detachment, glaucoma, and early cataracts. Skeletal system manifestations include bone overgrowth and joint laxity; disproportionately long extremities for the size of the trunk (dolichostenomelia); overgrowth of the ribs that can push the sternum in (pectus excavatum) or out (pectus carinatum); and scoliosis that ranges from mild to severe and progressive. The major morbidity and early mortality in Marfan syndrome relate to the cardiovascular system and include dilatation of the aorta at the level of the sinuses of Valsalva (predisposing to aortic tear and rupture), mitral valve prolapse with or without regurgitation, tricuspid valve prolapse, and enlargement of the proximal pulmonary artery. Severe and prolonged regurgitation of the mitral and/or aortic valve can predispose to left ventricular dysfunction and occasionally heart failure. With proper management, the life expectancy of someone with Marfan syndrome approximates that of the general population.</Attribute>
                <XRef ID="NBK1335" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301510</ID>
                <ID Source="BookShelf">NBK1335</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987429</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2012">
                <ID Source="PubMed">22237449</ID>
              </Citation>
              <Citation Type="general" Abbrev="CSANZ, 2007">
                <ID Source="PubMed">17188935</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHA, 2004">
                <ID Source="PubMed">15184297</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_Marfan.pdf</URL>
                <CitationText>Orphanet, Marfan Syndrome, 2007</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Loeys et al., 2010">
                <ID Source="PubMed">20591885</ID>
              </Citation>
              <Citation Type="general" Abbrev="CCS, 2014">
                <ID Source="PubMed">24882528</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173340</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAP, 2013">
                <ID Source="PubMed">24081994</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="CSANZ, 2017">
                <ID Source="PubMed">28161018</ID>
              </Citation>
              <XRef ID="284963" DB="Orphanet" />
              <XRef ID="558" DB="Orphanet" />
              <XRef ID="C0024796" DB="MedGen" />
              <XRef ID="MONDO:0007947" DB="MONDO" />
              <XRef Type="MIM" ID="154700" DB="OMIM" />
            </Trait>
            <Trait ID="35310" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME</ElementValue>
                <XRef Type="MIM" ID="616914" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0064" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0065" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0070" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0066" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0069" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan lipodystrophy syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MARFANOID-PROGEROID SYNDROME</ElementValue>
                <XRef Type="MIM" ID="616914" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MARFAN-PROGEROID-LIPODYSTROPHY SYNDROME</ElementValue>
                <XRef Type="MIM" ID="616914" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Progeroid and marfanoid aspect-lipodystrophy syndrome</ElementValue>
                <XRef ID="MONDO:0014831" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MFLS</ElementValue>
                <XRef Type="MIM" ID="616914" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17371" />
                <XRef ID="17371" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="300382" DB="Orphanet" />
              <XRef ID="C4310796" DB="MedGen" />
              <XRef ID="MONDO:0014831" DB="MONDO" />
              <XRef Type="MIM" ID="616914" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4948437" SubmissionDate="2022-05-31" DateLastUpdated="2022-06-11" DateCreated="2022-06-11">
        <ClinVarSubmissionID localKey="chr15:48779328dupA" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002525517" DateUpdated="2022-06-11" DateCreated="2022-06-11" Type="SCV" Version="1" SubmitterName="Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology" OrgID="507246" OrganizationCategory="other" OrgAbbreviation="AIC-CCMB" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.3534dup variant is not present in publicly available population databases like 1000 Genomes, Exome Variant Server (EVS), Exome Aggregation Consortium (ExAC), Genome Aggregation Database (gnomAD), dbSNP and Indian Exome Database. The variant is also not present in our in-house exome database. The variant was not previously reported to ClinVar, Human Genome Mutation Database (HGMD) and OMIM databases in any affected individuals. In-silico pathogenicity prediction programs like MutationTaster2, CADD, Varsome etc. predicted this variant to be likely deleterious. The variant causes frameshift at the 1179th amino acid position that creates a premature stop codon at 1192th amino acid position of the altered transcripts that may either results into a truncated protein or causes nonsense mediated decay of the mRNA.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <NamePlatform>Novaseq</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FBN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000138.5:c.3534dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="154700" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616914" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11548002</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4948437" TraitType="Disease" MappingType="XRef" MappingValue="154700" MappingRef="OMIM">
        <MedGen CUI="C0024796" Name="Marfan syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4948437" TraitType="Disease" MappingType="XRef" MappingValue="616914" MappingRef="OMIM">
        <MedGen CUI="C4310796" Name="Progeroid and marfanoid aspect-lipodystrophy syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

